Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Cash from Investing Activities (2016 - 2025)

Bio-Techne (TECH) has 17 years of Cash from Investing Activities data on record, last reported at -$5.9 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 17.67% year-over-year to -$5.9 million; the TTM value through Dec 2025 reached -$13.8 million, up 73.48%, while the annual FY2025 figure was -$35.2 million, 82.67% up from the prior year.
  • Cash from Investing Activities reached -$5.9 million in Q4 2025 per TECH's latest filing, down from $605000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $605000.0 in Q3 2025 and bottomed at -$241.1 million in Q1 2023.
  • Average Cash from Investing Activities over 5 years is -$41.6 million, with a median of -$12.7 million recorded in 2024.
  • Peak YoY movement for Cash from Investing Activities: tumbled 28001.55% in 2022, then soared 104.61% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$35.2 million in 2021, then surged by 99.69% to -$109000.0 in 2022, then plummeted by 21616.51% to -$23.7 million in 2023, then surged by 78.74% to -$5.0 million in 2024, then fell by 17.67% to -$5.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$5.9 million in Q4 2025, $605000.0 in Q3 2025, and $406000.0 in Q2 2025.